Matches in Wikidata for { <http://www.wikidata.org/entity/Q79846625> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q79846625 description "article scientifique publié en 2007" @default.
- Q79846625 description "artículu científicu espublizáu en payares de 2007" @default.
- Q79846625 description "im November 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79846625 description "scientific article published on 16 November 2007" @default.
- Q79846625 description "wetenschappelijk artikel" @default.
- Q79846625 description "наукова стаття, опублікована в листопаді 2007" @default.
- Q79846625 name "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 name "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 type Item @default.
- Q79846625 label "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 label "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 prefLabel "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 prefLabel "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 P1433 Q79846625-355AC1E5-9817-47DF-B92D-8996D9460D50 @default.
- Q79846625 P1476 Q79846625-77792D2C-4E79-405C-96EA-EE24C39676DA @default.
- Q79846625 P2093 Q79846625-0D199E4F-6F7F-46B2-8154-E68B6728C152 @default.
- Q79846625 P2093 Q79846625-0DDF20EC-D6C9-4087-9942-E2923F0FBD67 @default.
- Q79846625 P2093 Q79846625-3DD96AB6-2412-4F38-A20D-141BED3FE975 @default.
- Q79846625 P2093 Q79846625-72074A4F-C1A0-47CF-9F34-969890CC96E0 @default.
- Q79846625 P2093 Q79846625-80764097-6CF6-4358-B2C6-B62739E56170 @default.
- Q79846625 P2093 Q79846625-A16BEF7F-B471-4244-9554-D5C3FCF6D88E @default.
- Q79846625 P2093 Q79846625-BCFCB8B7-13EB-4ECD-921B-54E00E94284B @default.
- Q79846625 P2093 Q79846625-DEC0BBEA-E1A2-4150-BBA5-534B46747FDC @default.
- Q79846625 P2093 Q79846625-EF96833E-EDEF-48F4-8E5B-D69309152D5D @default.
- Q79846625 P2888 Q79846625-76DA30FC-FEDA-4E41-AF60-EA39AEAE22C3 @default.
- Q79846625 P304 Q79846625-F3CECE34-05D7-48FA-AA36-94EE231D4ED0 @default.
- Q79846625 P31 Q79846625-9B7F407A-2E64-436C-8252-CB6B834A88D8 @default.
- Q79846625 P356 Q79846625-A4E72471-72A8-4288-A357-E970DB0F33E8 @default.
- Q79846625 P433 Q79846625-A0593BA5-47ED-46F0-8A68-4C32E12D5B70 @default.
- Q79846625 P478 Q79846625-8B15E3F2-1669-4AF2-A482-0923D79A610D @default.
- Q79846625 P577 Q79846625-9215F879-8395-41B9-B3F3-FB27B3F6ACFB @default.
- Q79846625 P6179 Q79846625-E361D03E-8B19-45A5-BE6D-48D308C78717 @default.
- Q79846625 P698 Q79846625-3FE91D94-4643-4F54-B4BE-6D23F90A1E25 @default.
- Q79846625 P921 Q79846625-007DD5D4-EFDE-4FC3-97FB-AE7525A866A5 @default.
- Q79846625 P921 Q79846625-396A5BC8-540D-4E01-90BB-11803D68578F @default.
- Q79846625 P921 Q79846625-B91E4E82-E9B4-467D-B783-3D5B8C884AE9 @default.
- Q79846625 P921 Q79846625-BF56E131-348B-4A21-AC73-55A489F64305 @default.
- Q79846625 P921 Q79846625-FE8DC85F-C1EA-47C1-9EF5-B31511062ABB @default.
- Q79846625 P356 S10434-007-9654-7 @default.
- Q79846625 P698 18008108 @default.
- Q79846625 P1433 Q2853069 @default.
- Q79846625 P1476 "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903" @default.
- Q79846625 P2093 "Alan P Venook" @default.
- Q79846625 P2093 "Donna Niedzwiecki" @default.
- Q79846625 P2093 "Donna R Hollis" @default.
- Q79846625 P2093 "Edward W Martin" @default.
- Q79846625 P2093 "Hedy L Kindler" @default.
- Q79846625 P2093 "Mitchell C Posner" @default.
- Q79846625 P2093 "Richard L Schilsky" @default.
- Q79846625 P2093 "Richard M Goldberg" @default.
- Q79846625 P2093 "Robert J Mayer" @default.
- Q79846625 P2888 s10434-007-9654-7 @default.
- Q79846625 P304 "158-164" @default.
- Q79846625 P31 Q13442814 @default.
- Q79846625 P356 "10.1245/S10434-007-9654-7" @default.
- Q79846625 P433 "1" @default.
- Q79846625 P478 "15" @default.
- Q79846625 P577 "2007-11-16T00:00:00Z" @default.
- Q79846625 P6179 "1002296347" @default.
- Q79846625 P698 "18008108" @default.
- Q79846625 P921 Q1427096 @default.
- Q79846625 P921 Q188874 @default.
- Q79846625 P921 Q25493920 @default.
- Q79846625 P921 Q42824440 @default.
- Q79846625 P921 Q967453 @default.